On Oct. 1, the U.S. Patent and Trademark Office issued two trademarks to Scott Hemingway’s client, Omega Alpha Pharmaceuticals. But to obtain them, Hemingway had to do battle before the Trademark Trial and Appeal Board over whether his client’s use of the Greek letters in its name was “deceptive.”
The background to the TTAB’s March 26 decision in In Re Omega Alpha Pharmaceuticals Inc. is as follows. Omega Alpha filed an application with the U.S. Patent and Trademark office to register the Greek letters in its name for a variety of nutritional/herbal supplements.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]